Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience

BACKGROUND: In a retrospective analysis of a prospective single center registry we compared the use of bivalirudin, unfractionated heparin (UFH) monotherapy, UFH + abciximab in 1240 consecutive patients with acute coronary syndrome (ACS) undergoing stent implantation. RESULTS: Bivalirudin was associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohla, Miklos, Tentzeris, Ioannis, Freynhofer, Matthias K., Farhan, Serdar, Jarai, Rudolf, Egger, Florian, Weiss, Thomas W., Wojta, Johann, Geppert, Alexander, Kastrati, Adnan, Stone, Gregg W., Huber, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161760/
https://www.ncbi.nlm.nih.gov/pubmed/27624328
http://dx.doi.org/10.1007/s00508-016-1078-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161760/
https://www.ncbi.nlm.nih.gov/pubmed/27624328
http://dx.doi.org/10.1007/s00508-016-1078-6

Ejemplares similares